Importantly, however, HIF-2a inhibition did not significantly affect DLK1-mediated stem cell marker expression under normoxic conditions, suggesting that there are other mediators downstream of DLK1 that can contribute to DLK1 signaling in glioma. The gene discussed is DLK1; the disease is central nervous system cancer.